{"content":"<li class=\"n-box-item date-title\" data-end=\"1381550399\" data-start=\"1381464000\" data-txt=\"Friday, December 20, 2019\">Friday, October 11, 2013</li><li class=\"n-box-item sa-box-item\" data-id=\"1325202\" data-ts=\"1381527362\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1325202-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After-hours Gainers / Losers</a></h4><ul>     <li>\n<b>Top Gainers, as of 5:15 p.m.:</b> <a href=\"https://seekingalpha.com/symbol/GST\" title=\"Gastar Exploration Inc.\">GST</a> <font color=\"green\">+3.6%</font>. <a href=\"https://seekingalpha.com/symbol/RT\" title=\"Ruby Tuesday, Inc.\">RT</a> <font color=\"green\">+3.1%</font>. <a href=\"https://seekingalpha.com/symbol/IRWD\" title=\"Ironwood Pharmaceuticals, Inc.\">IRWD</a> <font color=\"green\">+2.4%</font>. <a href=\"https://seekingalpha.com/symbol/HMY\" title=\"Harmony Gold Mining Company Limited\">HMY</a> <font color=\"green\">+1.6%</font>. <a href=\"https://seekingalpha.com/symbol/S\" title=\"Sprint Corporation\">S</a> <font color=\"green\">+1.3%</font>.</li>\n<li>\n<b>Top Losers, </b><b><b> as of 5:15 p.m.</b>:</b> <a href=\"https://seekingalpha.com/symbol/CIE\" title=\"Cobalt International Energy, Inc.\">CIE</a> <font color=\"red\">-5.7%</font>. MPEL <font color=\"red\">-3.8%</font>. <a href=\"https://seekingalpha.com/symbol/SSYS\" title=\"Stratasys, Inc.\">SSYS</a> <font color=\"red\">-3.7%</font>. <a href=\"https://seekingalpha.com/symbol/SIG\" title=\"Signet Jewelers Limited\">SIG</a> <font color=\"red\">-2.5%</font>. <a href=\"https://seekingalpha.com/symbol/MBFI\" title=\"MB Financial Inc.\">MBFI</a> <font color=\"red\">-2.4%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1325202\" data-linked=\"After-hours Gainers / Losers\" data-tweet=\"$GST $RT $IRWD - After-hours Gainers / Losers https://seekingalpha.com/news/1325202-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/1325202-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1325102\" data-ts=\"1381524617\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BLOX\" target=\"_blank\">BLOX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1325102-infoblox-nears-highs-following-bullish-pac-crest-note\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Infoblox nears highs following bullish Pac Crest note</a></h4><ul>\n<li>\n<a href=\"http://blogs.barrons.com/techtraderdaily/2013/10/11/new-products-integration-with-vmw-feye-to-boost-blox-pacific-crest/\" target=\"_blank\">Pac Crest</a> has raised its Infoblox (<a href=\"https://seekingalpha.com/symbol/BLOX\" title=\"Infoblox Inc.\">BLOX</a> <font color=\"green\">+7.9%</font>) PT to $52 from $40, and sees demand for the company's network automation/management <a href=\"http://www.infoblox.com/products/network-automation\" target=\"_blank\">software</a> benefiting from the growing network complexity created by mobile, cloud, virtualization, and security platforms.</li>\n<li>The firm also notes only 6% of companies with 1K+ employees have deployed Infoblox's products, and sees integration deals with <a href=\"https://solutionexchange.vmware.com/store/products/the-infoblox-vmware-plug-in-for-vcenter-orchestrator#.UlhjvplfTh4\" target=\"_blank\">VMware</a> and <a href=\"http://www.net-security.org/secworld.php?id=14293\" target=\"_blank\">FireEye</a>.</li>\n<li>Pac Crest's note comes a day after shares got a boost from a <a href=\"https://seekingalpha.com/currents/post/1322772\" target=\"_blank\">Sterne Agee upgrade</a>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1325102\" data-linked=\"Infoblox nears highs following bullish Pac Crest note\" data-tweet=\"$BLOX - Infoblox nears highs following bullish Pac Crest note https://seekingalpha.com/news/1325102-infoblox-nears-highs-following-bullish-pac-crest-note?source=tweet\" data-url=\"https://seekingalpha.com/news/1325102-infoblox-nears-highs-following-bullish-pac-crest-note\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:50 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1325052\" data-ts=\"1381523226\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMRN\" target=\"_blank\">AMRN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1325052-amarin-finishes-sharply-lower-on-vascepa-snda-jitters\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amarin finishes sharply lower on Vascepa sNDA jitters</a></h4><ul>\n<li>Amarin (NASDAQ:<a href=\"https://seekingalpha.com/symbol/AMRN\" title=\"Amarin Corporation PLC\">AMRN</a>) closes down <font color=\"red\">20%</font> after investors get a look at briefing documents for next week's FDA Advisory Committee meeting. (see <a href=\"https://seekingalpha.com/currents/post/1324902\" target=\"_blank\">previous</a>)</li>\n<li>Leerink is apparently out saying that the vote for a label expansion could be \"<a href=\"https://twitter.com/matthewherper/status/388748546414874624\" target=\"_blank\">fairly close</a>.\"</li>\n<li>\n<em>The Street</em>'s Adam Feuerstein <a href=\"https://twitter.com/adamfeuerstein/status/388752304624500736\" target=\"_blank\">highlights</a> page 87, noting that a \"reviewer very much sounds like he wants CVOT data prior to ANCHOR [indication] approval.\"</li>\n<li>EMDAC date is next Wednesday.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1325052\" data-linked=\"Amarin finishes sharply lower on Vascepa sNDA jitters\" data-tweet=\"$AMRN - Amarin finishes sharply lower on Vascepa sNDA jitters https://seekingalpha.com/news/1325052-amarin-finishes-sharply-lower-on-vascepa-snda-jitters?source=tweet\" data-url=\"https://seekingalpha.com/news/1325052-amarin-finishes-sharply-lower-on-vascepa-snda-jitters\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:27 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1325042\" data-ts=\"1381522875\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1325042-weekly-etf-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Weekly ETF Gainers / Losers</a></h4><ul>     <li>\n<b>Gainers:</b> <a href=\"https://seekingalpha.com/symbol/ung\" title=\"The United States Natural Gas ETF, LP\">UNG</a> <font color=\"green\">+7.53%</font>. <a href=\"https://seekingalpha.com/symbol/gaz\" title=\"iPath DJ-UBS Natural Gas Total Return Sub-Index ETN\">GAZ</a> <font color=\"green\">+5.75%</font>. <a href=\"https://seekingalpha.com/symbol/epi\" title=\"WisdomTree India Earnings ETF\">EPI</a> <font color=\"green\">+3.15%</font>. <a href=\"https://seekingalpha.com/symbol/tan\" title=\"Guggenheim Solar ETF \">TAN</a> <font color=\"green\">+3.01%</font>. <a href=\"https://seekingalpha.com/symbol/vnq\" title=\"Vanguard REIT Index ETF\">VNQ</a> <font color=\"green\">+2.93%</font>.</li>\n<li>\n<b>Losers:</b> <a href=\"https://seekingalpha.com/symbol/gdxj\" title=\"Market Vectors Junior Gold Miners ETF\">GDXJ</a> <font color=\"red\">-9.51%</font>. <a href=\"https://seekingalpha.com/symbol/gdx\" title=\"Market Vectors Gold Miners ETF\">GDX</a> <font color=\"red\">-4.91%</font>. <a href=\"https://seekingalpha.com/symbol/ura\" title=\"Global X Uranium ETF\">URA</a> <font color=\"red\">-4.85%</font>. <a href=\"https://seekingalpha.com/symbol/phys\" title=\"Sprott Physical Gold Trust\">PHYS</a> <font color=\"red\">-3.76%</font>. <a href=\"https://seekingalpha.com/symbol/vxx\" title=\"iPath S&amp;P 500 VIX Short-Term Futures ETN\">VXX</a> <font color=\"red\">-3.59%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1325042\" data-linked=\"Weekly ETF Gainers / Losers\" data-tweet=\"$UNG $GAZ-OLD $EPI - Weekly ETF Gainers / Losers https://seekingalpha.com/news/1325042-weekly-etf-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/1325042-weekly-etf-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:21 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1324992\" data-ts=\"1381521478\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VVUS\" target=\"_blank\">VVUS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1324992-leerink-upbeat-on-vivus-after-stendra-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Leerink upbeat on Vivus after Stendra deal</a></h4><ul>\n<li>Leerink is out with some commentary on Vivus' (<a href=\"https://seekingalpha.com/symbol/VVUS\" title=\"Vivus, Inc.\">VVUS</a> <font color=\"green\">+8.6%</font>) Stendra <a href=\"https://seekingalpha.com/currents/post/1323942\" target=\"_blank\">deal</a> with Auxilium Pharmaceuticals (NASDAQ:<a href=\"https://seekingalpha.com/symbol/AUXL\" title=\"Auxilium Pharmaceuticals, Inc.\">AUXL</a>).</li>\n<li>Analyst Marko Kozul thinks the marketing agreement says something about the ability of VVUS' new management to strike deals \u2014 this of course bodes well for a potential Qsymia partnership.</li>\n<li>\"Possibly more important than the terms of this deal, could be that this  partnership demonstrates that the new VVUS management is capable of  executing on partnership deals,\"  Kozul notes, adding that although \"a  Qsymia partnership deal [will be] significantly more complex and provide  larger terms, the Strendra partnership [is] a step in the right  direction.\"</li>\n<li>Outperform rating reiterated, price target is $20.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1324992\" data-linked=\"Leerink upbeat on Vivus after Stendra deal\" data-tweet=\"$VVUS $VVUS $AUXL - Leerink upbeat on Vivus after Stendra deal https://seekingalpha.com/news/1324992-leerink-upbeat-on-vivus-after-stendra-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/1324992-leerink-upbeat-on-vivus-after-stendra-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:57 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1324982\" data-ts=\"1381520518\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NEM\" target=\"_blank\">NEM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1324982-newmont-mining-lower-as-impressive-gold-output-offset-by-copper\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Newmont Mining lower as impressive gold output offset by copper</a></h4><ul>     <li>Shares of Newmont Mining (<a href=\"https://seekingalpha.com/symbol/NEM\" title=\"Newmont Mining Corporation (Holding Company)\">NEM</a> <font color=\"red\">-2.4%</font>) are lower as <a href=\"https://seekingalpha.com/currents/post/1324942\" target=\"_blank\">gold prices plunge</a>, but the damage isn\u2019t as bad as other big gold miners, as news about NEM's <a href=\"https://seekingalpha.com/currents/post/1323552\" target=\"_blank\">strong Q3 gold production</a> may have offset somewhat the disappointment about its copper output.</li>     <li>J.P. Morgan analysts are <a href=\"http://blogs.barrons.com/stockstowatchtoday/2013/10/11/as-gold-falls-copper-hits-newmont-mining\" target=\"_blank\">impressed</a> with the gold numbers, leading them to expect a strong Q4 with increased production from the Nevada mine and more ounces from the new Akyem mine.</li>\n<li>In cutting its full-year copper production forecast, NEM blamed lower than expected throughput at its Boddington mine in Australia and lower than expected ore grade processed at its Batu Hijua operation in Indonesia.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1324982\" data-linked=\"Newmont Mining lower as impressive gold output offset by copper\" data-tweet=\"$NEM - Newmont Mining lower as impressive gold output offset by copper https://seekingalpha.com/news/1324982-newmont-mining-lower-as-impressive-gold-output-offset-by-copper?source=tweet\" data-url=\"https://seekingalpha.com/news/1324982-newmont-mining-lower-as-impressive-gold-output-offset-by-copper\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1324972\" data-ts=\"1381520005\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LXRX\" target=\"_blank\">LXRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1324972-gabelli-sees-upside-for-lexicon-after-sell-off\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gabelli sees upside for Lexicon after sell-off</a></h4><ul>\n<li>Gabelli's Kevin Kedra says Wednesday's <a href=\"https://seekingalpha.com/currents/post/1319962\" target=\"_blank\">sell-off</a> in shares of Lexicon Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/LXRX\" title=\"Lexicon Pharmaceuticals, Inc.\">LXRX</a> <font color=\"green\">+2.5%</font>) \u2014 triggered by news of telotristat etiprate's apparent lack of efficacy in terms of its affect on the pathogenesis of ulcerative colitis \u2014 should be viewed as a <a href=\"http://www.streetinsider.com/Analyst+Comments/Lexicon+Pharma+%28LXRX%29+Pullback+is+Buying+Opp%2C+Thinks+Gabelli/8770815.html\" target=\"_blank\">buying opportunity</a>.</li>\n<li>\"The primary near-term catalyst for the company will be a partnership with a major pharmaceutical company for LX4211 in diabetes,\" Kedra says, adding that \"positive data in patients with renal impairment should help differentiate the compound  from competitors and make it an attractive asset within diabetes.\"</li>\n<li>Gabelli's $4.75 target is well above current levels and doesn't include \"any benefit from either ulcerative colitis or IBS-d.\"</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1324972\" data-linked=\"Gabelli sees upside for Lexicon after sell-off\" data-tweet=\"$LXRX - Gabelli sees upside for Lexicon after sell-off https://seekingalpha.com/news/1324972-gabelli-sees-upside-for-lexicon-after-sell-off?source=tweet\" data-url=\"https://seekingalpha.com/news/1324972-gabelli-sees-upside-for-lexicon-after-sell-off\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:33 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1324942\" data-ts=\"1381517995\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOLD\" target=\"_blank\">GOLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1324942-gold-miners-broadly-weaker-as-gold-futures-plunge-nearly-30\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gold miners broadly weaker, as gold futures plunge nearly $30</a></h4><ul>     <li>Miners trade notably lower, with the Market Vectors Gold Miners ETF (<a href=\"https://seekingalpha.com/symbol/GDX\" title=\"VanEck Vectors Gold Miners ETF\">GDX</a> <font color=\"red\">-2.2%</font>) down sharply, as gold futures <a href=\"http://www.marketwatch.com/story/gold-tumbles-further-below-1300-on-deal-hopes-2013-10-11\" target=\"_blank\">slid $28.70/oz.</a> to $1268.20 after <a href=\"https://seekingalpha.com/currents/post/1324802\" target=\"_blank\">dropping nearly $25 in about a minute</a> earlier this morning.</li>     <li>ABX <font color=\"red\">-3.5%</font>, <a href=\"https://seekingalpha.com/symbol/FNV\" title=\"Franco-Nevada Corporation\">FNV</a> <font color=\"red\">-3.6%</font>, <a href=\"https://seekingalpha.com/symbol/GG\" title=\"Goldcorp Inc.\">GG</a> <font color=\"red\">-3.1%</font>, <a href=\"https://seekingalpha.com/symbol/GFI\" title=\"Gold Fields Limited\">GFI</a> <font color=\"red\">-3.1%</font>, <a href=\"https://seekingalpha.com/symbol/EGO\" title=\"Eldorado Gold Corporation\">EGO</a> <font color=\"red\">-3.5%</font>, <a href=\"https://seekingalpha.com/symbol/NGD\" title=\"New Gold Inc\">NGD</a> <font color=\"red\">-3.5%</font>, <a href=\"https://seekingalpha.com/symbol/AUQ\" title=\"AuRico Gold\">AUQ</a> <font color=\"red\">-3.3%</font>, <a href=\"https://seekingalpha.com/symbol/AUY\" title=\"Yamana Gold Inc.\">AUY</a> <font color=\"red\">-2.8%</font>, <a href=\"https://seekingalpha.com/symbol/RGLD\" title=\"Royal Gold, Inc.\">RGLD</a> <font color=\"red\">-2.9%</font>, <a href=\"https://seekingalpha.com/symbol/NEM\" title=\"Newmont Mining Corporation (Holding Company)\">NEM</a> <font color=\"red\">-2.1%</font>.</li>     <li>ETFs: <a href=\"https://seekingalpha.com/symbol/GDXJ\" title=\"VanEck Vectors Junior Gold Miners ETF\">GDXJ</a>, GLDX, <a href=\"https://seekingalpha.com/symbol/PSAU\" title=\"Invesco Global Gold and Precious Metals Portfolio ETF\">PSAU</a>, <a href=\"https://seekingalpha.com/symbol/NUGT\" title=\"Direxion Daily Gold Miners Index Bull 3x Shares ETF\">NUGT</a>, <a href=\"https://seekingalpha.com/symbol/DUST\" title=\"Direxion Daily Gold Miners Index Bear 3x Shares ETF\">DUST</a>, <a href=\"https://seekingalpha.com/symbol/GGGG\" title=\"Global X Pure Gold Miners ETF\">GGGG</a>, <a href=\"https://seekingalpha.com/symbol/RING\" title=\"iShares MSCI Global Gold Miners ETF\">RING</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1324942\" data-linked=\"Gold miners broadly weaker, as gold futures plunge nearly $30\" data-tweet=\"$GOLD $GDX $GOLD - Gold miners broadly weaker, as gold futures plunge nearly $30 https://seekingalpha.com/news/1324942-gold-miners-broadly-weaker-as-gold-futures-plunge-nearly-30?source=tweet\" data-url=\"https://seekingalpha.com/news/1324942-gold-miners-broadly-weaker-as-gold-futures-plunge-nearly-30\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>20&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1324902\" data-ts=\"1381517187\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMRN\" target=\"_blank\">AMRN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1324902-amarin-falls-as-investors-digest-advisory-committee-briefing-documents\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amarin falls as investors digest advisory committee briefing documents</a></h4><ul>     <li>Briefing documents are now available for Amarin's (<a href=\"https://seekingalpha.com/symbol/AMRN\" title=\"Amarin Corporation PLC\">AMRN</a> <font color=\"red\">-8.9%</font>) upcoming FDA Advisory Committee meeting regarding a high triglycerides and mixed dyslipidemia indication for <a href=\"https://seekingalpha.com/currents/search?query=vascepa\" target=\"_blank\">Vascepa</a>.</li>     <li>The stock is trading sharply lower as investors sift through the 115 page package.</li>     <li>It seems some traders are keying on the following statement from page 57: \"The changes in lipid and lipoprotein parameters from baseline to week 12 in the mineral oil placebo group are rather atypical for a trial that included a stabilization period for diet and lipid-lowering therapy, raising the possibility that mineral oil may not be as inert as assumed. If true, the treatment effects observed with AMR101 may be overestimated.\"</li>     <li>Full set of documents <a href=\"http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM370985.pdf\" target=\"_blank\">here</a>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1324902\" data-linked=\"Amarin falls as investors digest advisory committee briefing documents\" data-tweet=\"$AMRN - Amarin falls as investors digest advisory committee briefing documents https://seekingalpha.com/news/1324902-amarin-falls-as-investors-digest-advisory-committee-briefing-documents?source=tweet\" data-url=\"https://seekingalpha.com/news/1324902-amarin-falls-as-investors-digest-advisory-committee-briefing-documents\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1324882\" data-ts=\"1381516201\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CNX\" target=\"_blank\">CNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1324882-consol-financial-markets-not-recognizing-full-value-of-assets\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consol: Financial markets not recognizing full value of assets</a></h4><ul>     <li>Consol Energy (<a href=\"https://seekingalpha.com/symbol/CNX\" title=\"CNX Resources Corporation\">CNX</a> <font color=\"green\">+4.5%</font>), whose shares already had posted solid gains, shoot higher after the company responds to takeover speculation by noting that \"the financial markets are not  recognizing the full value of our world-class assets.\"</li>     <li>\"Although it is Consol Energy's long-standing policy not to comment on market rumors or speculation, Consol Energy confirms that the evaluation process regarding our corporate structure continues and all options are being considered.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"1324882\" data-linked=\"Consol: Financial markets not recognizing full value of assets\" data-tweet=\"$CNX - Consol: Financial markets not recognizing full value of assets https://seekingalpha.com/news/1324882-consol-financial-markets-not-recognizing-full-value-of-assets?source=tweet\" data-url=\"https://seekingalpha.com/news/1324882-consol-financial-markets-not-recognizing-full-value-of-assets\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:30 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1324872\" data-ts=\"1381515776\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NTR\" target=\"_blank\">NTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1324872-potash-corp-minus-1_5-percent-as-profit-guidance-cut\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Potash Corp. -1.5% as profit guidance cut</a></h4><ul>     <li>Potash's (POT <font color=\"red\">-1.5%</font>) <a href=\"https://seekingalpha.com/currents/post/1323672\" target=\"_blank\">downside Q3 guidance</a> shouldn't come as a surprise, particularly after Agrium cut its forecast <a href=\"https://seekingalpha.com/currents/post/1319192\" target=\"_blank\">earlier this week</a> as CEO Mike Wilson said \"the soap opera in Russia\" was weighing on potash prices.</li>     <li>The revision reflects \"<a href=\"http://www.ft.com/intl/cms/s/0/26616684-328a-11e3-91d2-00144feab7de.html#axzz2hLeY8y9r\" target=\"_blank\">acute market uncertainty</a>\" battering global potash markets, Raymond James analyst Steve Hansen says; with potash prices moving sharply lower across most importing regions, \u201cbuyers seem intent on deferring purchases with the hope of securing lower prices and improved macro visibility in the future.\u201d</li>     <li>But analysts say competition among suppliers is intensifying amid negotiations with the Chinese who are among the top potash buyers, pointing to a further fall in prices.</li>     <li>Also, <a href=\"https://seekingalpha.com/symbol/MOS\" title=\"The Mosaic Company\">MOS</a> <font color=\"red\">-2.1%</font>, AGU <font color=\"green\">+1%</font>, <a href=\"https://seekingalpha.com/symbol/IPI\" title=\"Intrepid Potash, Inc.\">IPI</a> <font color=\"red\">-0.2%</font>, <a href=\"https://seekingalpha.com/symbol/CF\" title=\"CF Industries Holdings, Inc.\">CF</a> <font color=\"red\">-1%</font>, <a href=\"https://seekingalpha.com/symbol/SQM\" title=\"Chemical &amp; Mining Co. of Chile Inc.\">SQM</a> <font color=\"red\">-2.1%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1324872\" data-linked=\"Potash Corp. -1.5% as profit guidance cut\" data-tweet=\"$NTR $NTR $MOS - Potash Corp. -1.5% as profit guidance cut https://seekingalpha.com/news/1324872-potash-corp-minus-1_5-percent-as-profit-guidance-cut?source=tweet\" data-url=\"https://seekingalpha.com/news/1324872-potash-corp-minus-1_5-percent-as-profit-guidance-cut\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1324802\" data-ts=\"1381513361\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1324802-gold-sell-off-tied-to-single-trade-nanex\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gold sell-off tied to single trade: Nanex</a></h4><ul>\n<li>Was <a href=\"http://www.cnbc.com/id/101106134\" target=\"_blank\">one trade responsible</a> for a sudden $25 drop in the price of gold Friday morning?</li>\n<li>The move lower \u2014 which happened in the space of 2 minutes and sent the yellow metal to a three-month low \u2014 is being blamed on a market order to sell 5K gold futures contracts, Nanex tells CNBC.</li>\n<li>\"About 2,700 went off and tripped the stop logic, halting gold futures  for 10 seconds while liquidity replenished. When enough liquidity  returned (after 10 seconds), the balance of about 2,300 completed,\" Nanex remarked.</li>\n<li>The move appears to have affected silver, platinum, and even oil.</li>\n<li>Gold <font color=\"red\">-2.15%</font>, silver <font color=\"red\">-3%</font>, platinum <font color=\"red\">-1.7%</font>, crude <font color=\"red\">-1.6%</font>\n</li>\n<li>Precious metals ETFs: <a href=\"https://seekingalpha.com/symbol/gld\" title=\"SPDR Gold Trust ETF\">GLD</a>, <a href=\"https://seekingalpha.com/symbol/iau\" title=\"iShares Gold Trust ETF\">IAU</a>, <a href=\"https://seekingalpha.com/symbol/sgol\" title=\"ETFS Physical Swiss Gold Trust ETF\">SGOL</a>, <a href=\"https://seekingalpha.com/symbol/phys\" title=\"Sprott Physical Gold Trust\">PHYS</a> <a href=\"https://seekingalpha.com/symbol/agol\" title=\"ETFS Physical Asian Gold Shares Trust ETF\">AGOL</a>, <a href=\"https://seekingalpha.com/symbol/dgl\" title=\"PowerShares DB Gold ETF\">DGL</a>, <a href=\"https://seekingalpha.com/symbol/ubg\" title=\"UBS ETRACS CMCI Gold Total Return ETN\">UBG</a>, <a href=\"https://seekingalpha.com/symbol/dgp\" title=\"PowerShares DB Gold Double Long ETN\">DGP</a>, <a href=\"https://seekingalpha.com/symbol/ugl\" title=\"ProShares Ultra Gold ETF\">UGL</a>, <a href=\"https://seekingalpha.com/symbol/dzz\" title=\"PowerShares DB Gold Double Short ETN\">DZZ</a>, <a href=\"https://seekingalpha.com/symbol/gll\" title=\"ProShares UltraShort Gold ETF\">GLL</a>, <a href=\"https://seekingalpha.com/symbol/dgz\" title=\"PowerShares DB Gold Short ETN\">DGZ</a>, <a href=\"https://seekingalpha.com/symbol/ugld\" title=\"VelocityShares 3x Long Gold ETN\">UGLD</a>, <a href=\"https://seekingalpha.com/symbol/dgld\" title=\"VelocityShares 3x Inverse Gold ETN\">DGLD</a>, <a href=\"https://seekingalpha.com/symbol/gldi\" title=\"Credit Suisse Gold Shares Covered Call ETN\">GLDI</a>, <a href=\"https://seekingalpha.com/symbol/slv\" title=\"iShares Silver Trust ETF\">SLV</a>, <a href=\"https://seekingalpha.com/symbol/sivr\" title=\"ETFS Silver Trust ETF\">SIVR</a>, <a href=\"https://seekingalpha.com/symbol/agq\" title=\"ProShares Ultra Silver ETF\">AGQ</a>, <a href=\"https://seekingalpha.com/symbol/dbs\" title=\"PowerShares DB Silver ETF\">DBS</a>, <a href=\"https://seekingalpha.com/symbol/usv\" title=\"UBS ETRACS CMCI Silver Total Return ETN\">USV</a>, <a href=\"https://seekingalpha.com/symbol/zsl\" title=\"ProShares UltraShort Silver ETF\">ZSL</a>, <a href=\"https://seekingalpha.com/symbol/uslv\" title=\"VelocityShares 3x Long Silver ETN\">USLV</a>, <a href=\"https://seekingalpha.com/symbol/dslv\" title=\"VelocityShares 3x Inverse Silver ETN\">DSLV</a>, <a href=\"https://seekingalpha.com/symbol/slvo\" title=\"Credit Suisse Silver Shares Covered Call ETN\">SLVO</a>\n</li>\n<li>Oil ETFs - <a href=\"https://seekingalpha.com/symbol/oil\" title=\"iPath S&amp;P Crude Oil Total Return Index ETN\">OIL</a>, <a href=\"https://seekingalpha.com/symbol/uso\" title=\"The United States Oil ETF, LP\">USO</a>, <a href=\"https://seekingalpha.com/symbol/dbo\" title=\"PowerShares DB Oil ETF\">DBO</a>, <a href=\"https://seekingalpha.com/symbol/olo\" title=\"PowerShares DB Crude Oil Long ETN\">OLO</a>, <a href=\"https://seekingalpha.com/symbol/usl\" title=\"The United States 12 Month Oil ETF, LP\">USL</a>, <a href=\"https://seekingalpha.com/symbol/crud\" title=\"Teucrium WTI Crude Oil ETF\">CRUD</a>, <a href=\"https://seekingalpha.com/symbol/uco\" title=\"ProShares Ultra DJ-UBS Crude Oil ETF\">UCO</a>, <a href=\"https://seekingalpha.com/symbol/dto\" title=\"PowerShares DB Crude Oil Double Short ETN\">DTO</a>, <a href=\"https://seekingalpha.com/symbol/sco\" title=\"ProShares UltraShort DJ-UBS Crude Oil ETF\">SCO</a>, <a href=\"https://seekingalpha.com/symbol/szo\" title=\"PowerShares DB Crude Oil Short ETN\">SZO</a>, <a href=\"https://seekingalpha.com/symbol/dno\" title=\"The United States Short Oil ETF, LP\">DNO</a>, <a href=\"https://seekingalpha.com/symbol/uwti\" title=\"VelocityShares 3x Long Crude Oil ETN\">UWTI</a>, <a href=\"https://seekingalpha.com/symbol/dwti\" title=\"VelocityShares 3x Inverse Crude Oil ETN\">DWTI</a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1324802\" data-linked=\"Gold sell-off tied to single trade: Nanex\" data-tweet=\"$GLD $IAU $SGOL - Gold sell-off tied to single trade: Nanex https://seekingalpha.com/news/1324802-gold-sell-off-tied-to-single-trade-nanex?source=tweet\" data-url=\"https://seekingalpha.com/news/1324802-gold-sell-off-tied-to-single-trade-nanex\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>77&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1324782\" data-ts=\"1381513040\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INFY\" target=\"_blank\">INFY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1324782-cognizant-wipro-accenture-up-in-sympathy-with-infosys\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cognizant, Wipro, Accenture up in sympathy with Infosys</a></h4><ul>\n<li>Infosys' (<a href=\"https://seekingalpha.com/symbol/INFY\" title=\"Infosys Limited, Inc.\">INFY</a> <font color=\"green\">+6.1%</font>) <a href=\"https://seekingalpha.com/currents/post/1323712\" target=\"_blank\">FQ2 beat</a> and in-line FY14 revenue guidance (9%-10% growth vs. 9.3% consensus) is providing a lift to IT outsourcing peers Cognizant (<a href=\"https://seekingalpha.com/symbol/CTSH\" title=\"Cognizant Technology Solutions Corporation\">CTSH</a> <font color=\"green\">+5.4%</font>), Wipro (<a href=\"https://seekingalpha.com/symbol/WIT\" title=\"Wipro Limited\">WIT</a> <font color=\"green\">+4.2%</font>), and Accenture (<a href=\"https://seekingalpha.com/symbol/ACN\" title=\"Accenture plc\">ACN</a> <font color=\"green\">+1.7%</font>)</li>\n<li>Cognizant and Wipro have made new 52-week highs. <a href=\"https://seekingalpha.com/currents/post/1134742\" target=\"_blank\">In July</a>, both companies rallied in response to Infosys' <a href=\"https://seekingalpha.com/currents/post/1133892\" target=\"_blank\">FQ1 beat</a>. All four companies <a href=\"https://seekingalpha.com/currents/post/1303372\" target=\"_blank\">sold off last month</a> after Cognizant provided soft revenue and bookings guidance (more the result of consulting weakness rather than outsourcing)</li>\n<li>Infosys' <a href=\"https://seekingalpha.com/article/1740372-infosys-management-discusses-q2-2014-results-earnings-call-transcript\" target=\"_blank\">CC remarks</a> could also be helping out the group. CEO S.D. Shibulal mentioned demand from financial services clients is picking up,  retail/consumer products demand remains healthy, and European firms are showing greater interest in outsourcing across verticals. However, manufacturing spend is \"relatively stagnant,\" and and the energy, utilities, and telecom verticals remain challenging.</li>\n<li>15 cloud/big data-related deals were signed in FQ2. Cloud services represent both a growth opportunity for outsourcing firms, and (to the extent in-house projects are abandoned for public cloud services) a long-term threat.</li>\n<li>The rupee's decline boosted Infosys' EBIT margin by 250 bps, but wage hikes took a 300 bps toll.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1324782\" data-linked=\"Cognizant, Wipro, Accenture up in sympathy with Infosys\" data-tweet=\"$INFY $INFY $CTSH - Cognizant, Wipro, Accenture up in sympathy with Infosys https://seekingalpha.com/news/1324782-cognizant-wipro-accenture-up-in-sympathy-with-infosys?source=tweet\" data-url=\"https://seekingalpha.com/news/1324782-cognizant-wipro-accenture-up-in-sympathy-with-infosys\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:37 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1324702\" data-ts=\"1381509964\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1324702-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li>\n<b>Top 10 Gainers:</b> SCTY <font color=\"green\">+22%</font>. <a href=\"https://seekingalpha.com/symbol/LLEN\" title=\"L&amp;L Energy, Inc.\">LLEN</a> <font color=\"green\">+18%</font>. <a href=\"https://seekingalpha.com/symbol/ENV\" title=\"Envestnet, Inc.\">ENV</a> <font color=\"green\">+17%</font>. <a href=\"https://seekingalpha.com/symbol/KGJI\" title=\"KINGOLD JEWELRY\">KGJI</a> <font color=\"green\">+16%</font>. <a href=\"https://seekingalpha.com/symbol/PRIS\" title=\"Promotora de Informaciones, S.A.\">PRIS</a> <font color=\"green\">+16%</font>. <a href=\"https://seekingalpha.com/symbol/ZAZA\" title=\"ZaZa Energy Corp\">OTC:ZAZA</a> <font color=\"green\">+16%</font>. <a href=\"https://seekingalpha.com/symbol/CYTK\" title=\"Cytokinetics, Incorporated\">CYTK</a> <font color=\"green\">+16%</font>. SBSA <font color=\"green\">+15%</font>. <a href=\"https://seekingalpha.com/symbol/KUTV\" title=\"Ku6 Media Co., Ltd.\">KUTV</a> <font color=\"green\">+15%</font>. <a href=\"https://seekingalpha.com/symbol/ALTI\" title=\"Altair Nanotechnologies Inc.\">ALTI</a> <font color=\"green\">+14%</font>.</li>\n<li>\n<b>Top 10 Losers:</b> <a href=\"https://seekingalpha.com/symbol/LBIX-OLD\" title=\"Leading Brands Inc\">LBIX-OLD</a> <font color=\"red\">-16%</font>. <a href=\"https://seekingalpha.com/symbol/PRKR\" title=\"ParkerVision, Inc.\">OTC:PRKR</a> <font color=\"red\">-14%</font>. <a href=\"https://seekingalpha.com/symbol/ARIA\" title=\"ARIAD Pharmaceuticals, Inc.\">ARIA</a> <font color=\"red\">-14%</font>. <a href=\"https://seekingalpha.com/symbol/MRCY\" title=\"Mercury Systems, Inc.\">MRCY</a> <font color=\"red\">-12%</font>. <a href=\"https://seekingalpha.com/symbol/CRAY\" title=\"Cray Inc\">CRAY</a> <font color=\"red\">-11%</font>. <a href=\"https://seekingalpha.com/symbol/SGI\" title=\"Silicon Graphics Inc.\">SGI</a> <font color=\"red\">-10%</font>. <a href=\"https://seekingalpha.com/symbol/IESC\" title=\"Integrated Electrical Services, Inc.\">IESC</a> <font color=\"red\">-10%</font>. <a href=\"https://seekingalpha.com/symbol/GRO\" title=\"Agria Corporation\">GRO</a> <font color=\"red\">-9%</font>. <a href=\"https://seekingalpha.com/symbol/NPSP\" title=\"NPS Pharmaceuticals, Inc.\">NPSP</a> <font color=\"red\">-9%</font>. <a href=\"https://seekingalpha.com/symbol/GORO\" title=\"Gold Resource Corporation\">GORO</a> <font color=\"red\">-8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1324702\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$TSLA $LLEN $ENV - Midday Gainers / Losers https://seekingalpha.com/news/1324702-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/1324702-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:46 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1324622\" data-ts=\"1381506400\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ANDV\" target=\"_blank\">ANDV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1324622-refiners-rally-as-epa-declares-ethanol-blend-wall-a-reality\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Refiners rally as EPA declares ethanol blend wall a reality</a></h4><ul>     <li>Refiners continue to rise a day after news of a leaked EPA proposal that would significantly <a href=\"https://seekingalpha.com/currents/post/1323202\" target=\"_blank\">scale back biofuel blending requirements next year</a>.</li>     <li>The EPA's rationale for a cut in the volume of  ethanol that must be blended echoes an argument the oil industry has made for months: The U.S. fuel chain cannot absorb more ethanol.</li>     <li>\n<a href=\"http://www.reuters.com/article/2013/10/11/us-ethanol-blendwall-analysis-idUSBRE99A09420131011\" target=\"_blank\">Let the lawsuits begin</a>: \"Any plan to roll back the targets... under the guise of addressing the blend wall would be patently unlawful,\" says the head of the Renewable Fuels Association.</li>     <li>TSO <font color=\"green\">+4.4%</font>, <a href=\"https://seekingalpha.com/symbol/VLO\" title=\"Valero Energy Corporation\">VLO</a> <font color=\"green\">+3.4%</font>, <a href=\"https://seekingalpha.com/symbol/PSX\" title=\"Phillips 66\">PSX</a> <font color=\"green\">+3.1%</font>, <a href=\"https://seekingalpha.com/symbol/MPC\" title=\"Marathon Petroleum Corp.\">MPC</a> <font color=\"green\">+2.2%</font>, <a href=\"https://seekingalpha.com/symbol/WNR\" title=\"Western Refining, Inc.\">WNR</a> <font color=\"green\">+4.5%</font>, <a href=\"https://seekingalpha.com/symbol/HFC\" title=\"HollyFrontier Corp.\">HFC</a> <font color=\"green\">+2.2%</font>, <a href=\"https://seekingalpha.com/symbol/ALJ\" title=\"Alon USA Energy, Inc.\">ALJ</a> <font color=\"green\">+6.8%</font>, <a href=\"https://seekingalpha.com/symbol/CVI\" title=\"CVR Energy, Inc.\">CVI</a> <font color=\"green\">+2.6%</font>, <a href=\"https://seekingalpha.com/symbol/NTI\" title=\"Northern Tier Energy\">NTI</a> <font color=\"green\">+2%</font>, <a href=\"https://seekingalpha.com/symbol/DK\" title=\"Delek US Holdings, Inc.\">DK</a> <font color=\"green\">+7.8%</font>, <a href=\"https://seekingalpha.com/symbol/CLMT\" title=\"Calumet Specialty Products Partners, L.P.\">CLMT</a> <font color=\"green\">+1.8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1324622\" data-linked=\"Refiners rally as EPA declares ethanol blend wall a reality\" data-tweet=\"$ANDV $ANDV $VLO - Refiners rally as EPA declares ethanol blend wall a reality https://seekingalpha.com/news/1324622-refiners-rally-as-epa-declares-ethanol-blend-wall-a-reality?source=tweet\" data-url=\"https://seekingalpha.com/news/1324622-refiners-rally-as-epa-declares-ethanol-blend-wall-a-reality\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1324612\" data-ts=\"1381505947\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARIA\" target=\"_blank\">ARIA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1324612-ariad-slides-again-as-fda-details-adverse-event-reports\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ariad slides again as FDA details adverse event reports</a></h4><ul>\n<li>Ariad Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/ARIA\" title=\"ARIAD Pharmaceuticals, Inc.\">ARIA</a> <font color=\"red\">-15.1%</font>) takes another big hit on the heels of Wednesday's <a href=\"https://seekingalpha.com/currents/post/1320042\" target=\"_blank\">rout</a>.</li>\n<li>The FDA posted a drug safety communication on <a href=\"https://seekingalpha.com/currents/search?query=iclusig\" target=\"_blank\">Iclusig</a> today which contained the following rather disconcerting language: \"FDA is investigating an increasing frequency of reports of serious and  life-threatening blood clots and severe narrowing of blood vessels of patients taking ponatinib ... including heart attacks resulting in death,  worsening coronary artery disease, stroke, narrowing of large arteries  of the brain, severe narrowing of blood vessels in the extremities, and  the need for urgent surgical procedures to restore blood flow.\" (<a href=\"http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm370971.htm\" target=\"_blank\">full report</a>)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1324612\" data-linked=\"Ariad slides again as FDA details adverse event reports\" data-tweet=\"$ARIA - Ariad slides again as FDA details adverse event reports https://seekingalpha.com/news/1324612-ariad-slides-again-as-fda-details-adverse-event-reports?source=tweet\" data-url=\"https://seekingalpha.com/news/1324612-ariad-slides-again-as-fda-details-adverse-event-reports\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1324492\" data-ts=\"1381502596\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MYGN\" target=\"_blank\">MYGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1324492-myriad-genetics-falls-as-suntrust-sees-pricing-pressure\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Myriad Genetics falls as SunTrust sees pricing pressure</a></h4><ul>\n<li>Myriad Genetics (<a href=\"https://seekingalpha.com/symbol/MYGN\" title=\"Myriad Genetics, Inc.\">MYGN</a> <font color=\"red\">-6%</font>) slides as SunTrust <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/13/10/3985308/update-suntrust-initiates-coverage-on-myriad-genetics-on#\" target=\"_blank\">raises pricing questions </a>(something MYGN investors certainly do not want to hear about).</li>\n<li>\"The most imminent threat from new competitors for BRACAnalysis is not market share, buy pricing pressures,\" analyst Amit Hazan says, adding that \"private insurer re-evaluation is currently ongoing ... and  could realistically drive the price down by as much as 50% over the next  two years.\"</li>\n<li>MYGN initiated at Reduce.</li>\n<li>Price target is $17.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1324492\" data-linked=\"Myriad Genetics falls as SunTrust sees pricing pressure\" data-tweet=\"$MYGN - Myriad Genetics falls as SunTrust sees pricing pressure https://seekingalpha.com/news/1324492-myriad-genetics-falls-as-suntrust-sees-pricing-pressure?source=tweet\" data-url=\"https://seekingalpha.com/news/1324492-myriad-genetics-falls-as-suntrust-sees-pricing-pressure\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:43 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1324462\" data-ts=\"1381501949\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPWR\" target=\"_blank\">SPWR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1324462-solar-stocks-follow-solarcity-higher\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Solar stocks follow SolarCity higher</a></h4><ul>     <li>Two days after <a href=\"https://seekingalpha.com/currents/post/1321002\" target=\"_blank\">tumbling</a> as the government shutdown spawned a general selloff in risk assets, solar stocks are bouncing with the help of <a href=\"https://seekingalpha.com/currents/post/1324342\" target=\"_blank\">strong Q3 numbers</a> and even stronger 2014 guidance from SolarCity. The numbers shine a light on the <a href=\"https://seekingalpha.com/currents/post/1275372\" target=\"_blank\">strong installation growth</a> being seen in the U.S. market.</li>     <li>Notable gainers: <a href='https://seekingalpha.com/symbol/SPWR' title='SunPower Corporation'>SPWR</a> <font color='green'>+5%</font>. <a href='https://seekingalpha.com/symbol/FSLR' title='First Solar, Inc.'>FSLR</a> <font color='green'>+3.3%</font>. <a href='https://seekingalpha.com/symbol/TSL' title='Trina Solar Limited'>TSL</a> <font color='green'>+5.7%</font>. <a href='https://seekingalpha.com/symbol/YGE' title='Yingli Green Energy Holding Company Limited'>YGE</a> <font color='green'>+3.6%</font>. <a href='https://seekingalpha.com/symbol/JKS' title='JinkoSolar Holding Co., Ltd.'>JKS</a> <font color='green'>+4.4%</font>. <a href='https://seekingalpha.com/symbol/CSIQ' title='Canadian Solar Inc.'>CSIQ</a> <font color='green'>+3.9%</font>. <a href='https://seekingalpha.com/symbol/JASO' title='JA Solar Holdings, Co., Ltd.'>JASO</a> <font color='green'>+3.9%</font>. <a href='https://seekingalpha.com/symbol/DQ' title='DAQO New Energy Corp.'>DQ</a> <font color='green'>+3.4%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1324462\" data-linked=\"Solar stocks follow SolarCity higher\" data-tweet=\"$SPWR $SPWR $FSLR - Solar stocks follow SolarCity higher https://seekingalpha.com/news/1324462-solar-stocks-follow-solarcity-higher?source=tweet\" data-url=\"https://seekingalpha.com/news/1324462-solar-stocks-follow-solarcity-higher\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1324452\" data-ts=\"1381501865\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CIE\" target=\"_blank\">CIE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1324452-cobalt-energy-plus-4_5-percent-on-mavingaminus-1-flow-test-off-angola\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cobalt Energy +4.5% on Mavinga-1 flow test off Angola</a></h4><ul>     <li>Cobalt Energy (<a href=\"https://seekingalpha.com/symbol/CIE\" title=\"Cobalt International Energy, Inc.\">CIE</a> <font color=\"green\">+4.5</font>) is believed to be running a flow test on its  Mavinga-1 exploration well off Angola, raising the prospect the operator  <a href=\"http://www.upstreamonline.com/hardcopy/news/article1340064.ece\" target=\"_blank\">may have a third pre-salt discovery</a> in the country, <em>Upstream</em> reports.</li>     <li>Test results of CIE's Cameia #1 discovery confirmed the presence of an expansive pre-salt hydrocarbon reservoir offshore Angola, and the  Cameia #2 appraisal well has provided validating evidence allowing more work toward the sanctioning of an early production system, according to the company website.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1324452\" data-linked=\"Cobalt Energy +4.5% on Mavinga-1 flow test off Angola\" data-tweet=\"$CIE - Cobalt Energy +4.5% on Mavinga-1 flow test off Angola https://seekingalpha.com/news/1324452-cobalt-energy-plus-4_5-percent-on-mavingaminus-1-flow-test-off-angola?source=tweet\" data-url=\"https://seekingalpha.com/news/1324452-cobalt-energy-plus-4_5-percent-on-mavingaminus-1-flow-test-off-angola\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1324432\" data-ts=\"1381501556\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CYTK\" target=\"_blank\">CYTK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1324432-cytokinetics-jumps-as-needham-reiterates-omecamtiv-bull-thesis\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cytokinetics jumps as Needham reiterates omecamtiv bull thesis</a></h4><ul>\n<li>Cytokinetics (<a href=\"https://seekingalpha.com/symbol/CYTK\" title=\"Cytokinetics, Incorporated\">CYTK</a> <font color=\"green\">+7.6%</font>) rallies after Needham's Chad Messer reminds investors that despite a misread by the media, last month's ATOMIC-AHF <a href=\"https://seekingalpha.com/currents/post/1256042\" target=\"_blank\">readout</a> was actually <a href=\"http://www.streetinsider.com/Analyst+Comments/Needham+%26+Company+Says+Buy+Cytokinetics+%28CYTK%29+as+Market+Misread+of+Omecamtiv+Data/8770471.html\" target=\"_blank\">in line with expectations</a>.</li>\n<li>\"Significant increases in systolic injection and  reduction in worsening of heart failure while actually lowering heart  rate, distinguish omecamtiv from older inotropic agents [and] are more than positive enough for Amgen (NASDAQ:<a href=\"https://seekingalpha.com/symbol/AMGN\" title=\"Amgen Inc.\">AMGN</a>) to proceed  with a Phase 3 study next year, triggering a milestone  payment to CYTK shareholders,\" Messer notes, downplaying the overall dypsnea response miss.<br>\n</li>\n<li>Price target raised to $25 from $20.</li>\n<li>While today's vote of confidence is good for morale, the rationale here was <a href=\"https://seekingalpha.com/currents/post/1256812\" target=\"_blank\">discussed at length</a> in early September after the presentation at the ESC Congress. <br>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1324432\" data-linked=\"Cytokinetics jumps as Needham reiterates omecamtiv bull thesis\" data-tweet=\"$CYTK $CYTK $AMGN - Cytokinetics jumps as Needham reiterates omecamtiv bull thesis https://seekingalpha.com/news/1324432-cytokinetics-jumps-as-needham-reiterates-omecamtiv-bull-thesis?source=tweet\" data-url=\"https://seekingalpha.com/news/1324432-cytokinetics-jumps-as-needham-reiterates-omecamtiv-bull-thesis\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1324412\" data-ts=\"1381501001\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SDRL\" target=\"_blank\">SDRL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1324412-seadrill-partners-says-rig-settlement-to-hit-q3-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Seadrill Partners says rig settlement to hit Q3 results</a></h4><ul>     <li>Seadrill Partners (<a href=\"https://seekingalpha.com/symbol/SDRL\" title=\"Seadrill Limited (New)\">SDRL</a> <font color=\"red\">-2.6%</font>) says <a href=\"http://finance.yahoo.com/news/sdlp-seadrill-partners-llc-announces-194003371.html\" target=\"_blank\">Q3 results will be negatively impacted</a> by a settlement where it agreed to non-payment for 37 days during the recent mobilization period as a result of the time required for the West Aquarius rig to complete modifications and repairs in order to meet Canadian regulatory  requirements.</li>\n<li>SDRL also says it is negotiating an 18-month contract extension for the rig off Canada's east coast until April 2017, which it expects to be executed by Nov. 30; total revenue potential for the extension is estimated at $337M, the extension would increase SDRL's  average contract term to 3.8 years from 3.5, and raise its contracted backlog to $2.9B from $2.6B.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1324412\" data-linked=\"Seadrill Partners says rig settlement to hit Q3 results\" data-tweet=\"$SDRL - Seadrill Partners says rig settlement to hit Q3 results https://seekingalpha.com/news/1324412-seadrill-partners-says-rig-settlement-to-hit-q3-results?source=tweet\" data-url=\"https://seekingalpha.com/news/1324412-seadrill-partners-says-rig-settlement-to-hit-q3-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1324402\" data-ts=\"1381500786\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRAY\" target=\"_blank\">CRAY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1324402-cray-dives-in-sympathy-with-sgi\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cray dives in sympathy with SGI</a></h4><ul>\n<li>Cray (<a href=\"https://seekingalpha.com/symbol/CRAY\" title=\"Cray Inc\">CRAY</a> <font color=\"red\">-9.9%</font>) is down nearly as much as Silicon Graphics after the latter company issued a <a href=\"https://seekingalpha.com/currents/post/1323682\" target=\"_blank\">Sep. quarter warning</a> while blaming the government shutdown and longer sales cycles for the supercomputer/HPC, big data/analytics, and high-performance storage markets it's pushing into.</li>\n<li>Cray's <a href=\"http://www.cray.com/Products/Products.aspx\" target=\"_blank\">product line</a> targets the same markets, and the company is even more dependent on federal government orders than SGI. However, the company has been <a href=\"http://investors.cray.com/phoenix.zhtml?c=98390&amp;p=irol-newsArticle&amp;ID=1840893&amp;highlight=\" target=\"_blank\">growing its exposure</a> to foreign government entities.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1324402\" data-linked=\"Cray dives in sympathy with SGI\" data-tweet=\"$CRAY - Cray dives in sympathy with SGI https://seekingalpha.com/news/1324402-cray-dives-in-sympathy-with-sgi?source=tweet\" data-url=\"https://seekingalpha.com/news/1324402-cray-dives-in-sympathy-with-sgi\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:13 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1324362\" data-ts=\"1381499744\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SGEN\" target=\"_blank\">SGEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1324362-seattle-genetics-trades-lower-after-highlighting-new-adcetris-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Seattle Genetics trades lower after highlighting new Adcetris data</a></h4><ul>\n<li>Shares of Seattle Genetics (<a href=\"https://seekingalpha.com/symbol/SGEN\" title=\"Seattle Genetics, Inc.\">SGEN</a> <font color=\"red\">-1.8%</font>) are notably weaker in morning trading.</li>\n<li>In one investigator-sponsored Phase 2 trial enrolling seven untreated advanced stage HL patients, the company said that after two cycles of treatment, \"all       patients experienced Grade 3 or higher adverse events, including       neutropenia (three patients), diarrhea (three patients), infection (two       patients) and pancreatitis (two patients).\"</li>\n<li>SGEN noted that in this particular trial, \"one patient death occurred       due to acute pancreatitis.\"</li>\n<li>\"Enrollment of the study was temporarily       suspended but has since re-opened with monitoring of pancreatic enzymes       as well as an exclusion criterion for prior history of pancreatitis,\" the company notes. (PR)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1324362\" data-linked=\"Seattle Genetics trades lower after highlighting new Adcetris data\" data-tweet=\"$SGEN - Seattle Genetics trades lower after highlighting new Adcetris data https://seekingalpha.com/news/1324362-seattle-genetics-trades-lower-after-highlighting-new-adcetris-data?source=tweet\" data-url=\"https://seekingalpha.com/news/1324362-seattle-genetics-trades-lower-after-highlighting-new-adcetris-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1324342\" data-ts=\"1381499636\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSLA\" target=\"_blank\">TSLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1324342-solarcity-soars-after-reporting-q3-metrics-issuing-strong-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SolarCity soars after reporting Q3 metrics, issuing strong guidance</a></h4><ul>\n<li>SolarCity (SCTY <font color=\"green\">+17.4%</font>) says its deployed 78MW of capacity in Q3, above guidance of 70MW-77MW. Cumulative energy contracts +33% Q/Q to 72.5K, estimated nominal contracted payments remaining from customers +23% Q/Q to $1.74B (was only +15% in Q2), and cumulative customers +28% Q/Q (also only +15% in Q2). (PR)</li>\n<li>The company still expects 278MW of 2013 deployments (<a href=\"https://seekingalpha.com/currents/post/1218402\" target=\"_blank\">raised</a> from 270MW in August). But it's now guiding for 475MW-525MW of deployments in 2014 (up 71%-88% Y/Y). Analysts <a href=\"http://finance.yahoo.com/q/ae?s=scty&amp;ql=1\" target=\"_blank\">currently expect</a> 2014 revenue growth of 60.5%.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1324342\" data-linked=\"SolarCity soars after reporting Q3 metrics, issuing strong guidance\" data-tweet=\"$TSLA - SolarCity soars after reporting Q3 metrics, issuing strong guidance https://seekingalpha.com/news/1324342-solarcity-soars-after-reporting-q3-metrics-issuing-strong-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/1324342-solarcity-soars-after-reporting-q3-metrics-issuing-strong-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1324322\" data-ts=\"1381498858\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VVUS\" target=\"_blank\">VVUS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1324322-weekly-ims-data-for-key-weight-loss-drugs\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Weekly IMS data for key weight-loss drugs</a></h4><ul><li>Qsymia (<a href='https://seekingalpha.com/symbol/VVUS' title='Vivus, Inc.'>VVUS</a> <font color='green'>+3.8%</font>) TRx for week ending 10/04: <strong>10,762</strong> (+2.7% W/W).</li><li>Belviq (<a href='https://seekingalpha.com/symbol/ARNA' title='Arena Pharmaceuticals, Inc.'>ARNA</a> <font color='red'>-3.4%</font>) TRx for week ending 10/04: <strong>3,999</strong> (-1% W/W).</li><li>Courtesy: <a href=\"https://twitter.com/AndyBiotech/status/388658170169544704\" target=\"_blank\">Andy Biotech</a></li></ul><div class=\"tiny-share-widget\" data-id=\"1324322\" data-linked=\"Weekly IMS data for key weight-loss drugs\" data-tweet=\"$VVUS $VVUS $ARNA - Weekly IMS data for key weight-loss drugs https://seekingalpha.com/news/1324322-weekly-ims-data-for-key-weight-loss-drugs?source=tweet\" data-url=\"https://seekingalpha.com/news/1324322-weekly-ims-data-for-key-weight-loss-drugs\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1324312\" data-ts=\"1381498523\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1324312-progress-on-u-s-political-deadlock-sends-southeast-asian-shares-broadly-higher\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Progress on U.S. political deadlock sends Southeast Asian shares broadly higher</a></h4><ul><li>Southeast Asian markets are higher across the board on optimism regarding the U.S. political stalemate.</li><li>Shares in Thailand (<a href='https://seekingalpha.com/symbol/thd' title='iShares MSCI Thailand Capped ETF'>THD</a>, <a href='https://seekingalpha.com/symbol/tf' title='Thai Capital Fund'>TF</a>, <a href='https://seekingalpha.com/symbol/ttf' title='Thai Fund'>TTF</a>), Indonesia (<a href='https://seekingalpha.com/symbol/idx' title='Market Vectors Indonesia Index ETF'>IDX</a>, <a href='https://seekingalpha.com/symbol/idxj' title='Market Vectors Indonesia Small Cap ETF'>IDXJ</a>, <a href='https://seekingalpha.com/symbol/eido' title='iShares MSCI Indonesia ETF'>EIDO</a>), The Philippines (<a href='https://seekingalpha.com/symbol/ephe' title='iShares MSCI Philippines ETF'>EPHE</a>), Singapore (<a href='https://seekingalpha.com/symbol/ews' title='iShares MSCI Singapore ETF'>EWS</a>, <a href='https://seekingalpha.com/symbol/ewss' title='iShares MSCI Singapore Small-Cap ETF'>EWSS</a>), and Malaysia (<a href='https://seekingalpha.com/symbol/ewm' title='iShares MSCI Malaysia ETF'>EWM</a>) rise <font color='green'>0.4%</font>, <font color='green'>0.75%</font>, <font color='green'>0.8%</font>,<font color='green'> 0.3%</font>, and <font color='green'>0.55%</font> respectively.</li><li>Virtually all indices are sitting at multi-week highs.</li></ul><div class=\"tiny-share-widget\" data-id=\"1324312\" data-linked=\"Progress on U.S. political deadlock sends Southeast Asian shares broadly higher\" data-tweet=\"$THD $TF-OLD $TTF - Progress on U.S. political deadlock sends Southeast Asian shares broadly higher https://seekingalpha.com/news/1324312-progress-on-u-s-political-deadlock-sends-southeast-asian-shares-broadly-higher?source=tweet\" data-url=\"https://seekingalpha.com/news/1324312-progress-on-u-s-political-deadlock-sends-southeast-asian-shares-broadly-higher\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:35 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1324282\" data-ts=\"1381497986\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NPSP\" target=\"_blank\">NPSP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1324282-nps-pharma-slides-cramer-says-sell-some-red-hot-biotechs\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NPS Pharma slides, Cramer says sell some red-hot biotechs</a></h4><ul>     <li>It appears a large number of NPS Pharmaceuticals (NASDAQ:<a href=\"https://seekingalpha.com/symbol/NPSP\" title=\"NPS Pharmaceuticals, Inc.\">NPSP</a>) shares were sold Friday morning at $32 each.</li>     <li>The company itself was not a part of the transaction. According to NPSP, \"these were shares that were held by Takeda  that they sold to Jefferies in a block trade and Jefferies has re-sold  the shares through its sales distribution network.\"</li>     <li>Thursday evening, Cramer <a href=\"http://www.cnbc.com/id/101103707\" target=\"_blank\">recommended</a> \"ringing the register on   pretty much any biotech that's smaller than $10B.\" Stocks mentioned: NPSP, ISIS, <a href=\"https://seekingalpha.com/symbol/CLDX\" title=\"Celldex Therapeutics, Inc\">CLDX</a>, <a href=\"https://seekingalpha.com/symbol/ACAD\" title=\"ACADIA Pharmaceuticals Inc.\">ACAD</a>, <a href=\"https://seekingalpha.com/symbol/TSRO\" title=\"Tesaro\">TSRO</a>\n</li> </ul><div class=\"tiny-share-widget\" data-id=\"1324282\" data-linked=\"NPS Pharma slides, Cramer says sell some red-hot biotechs\" data-tweet=\"$NPSP $NPSP $IONS - NPS Pharma slides, Cramer says sell some red-hot biotechs https://seekingalpha.com/news/1324282-nps-pharma-slides-cramer-says-sell-some-red-hot-biotechs?source=tweet\" data-url=\"https://seekingalpha.com/news/1324282-nps-pharma-slides-cramer-says-sell-some-red-hot-biotechs\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1324272\" data-ts=\"1381497801\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INTC\" target=\"_blank\">INTC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1324272-a-roundup-of-tech-ratings-changes\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">A roundup of tech ratings changes</a></h4><ul>     <li>Intel (NASDAQ:<a href=\"https://seekingalpha.com/symbol/INTC\" title=\"Intel Corporation\">INTC</a>) has been cut to Neutral, and Nvidia (NASDAQ:<a href=\"https://seekingalpha.com/symbol/NVDA\" title=\"NVIDIA Corporation\">NVDA</a>) to Underperform, by Macquarie. Intel's Q3 report arrives on Tuesday. Intel <font color=\"red\">-0.6%</font> premarket, Nvidia <font color=\"red\">-0.9%</font>.</li>     <li>Micron (NASDAQ:<a href=\"https://seekingalpha.com/symbol/MU\" title=\"Micron Technology Inc.\">MU</a>) has been cut to Underperform by Wells Fargo following its FQ4 results (<a href=\"https://seekingalpha.com/currents/post/1323342\" target=\"_blank\">I</a>, <a href=\"https://seekingalpha.com/currents/post/1323412\" target=\"_blank\">II</a>) and <a href=\"https://seekingalpha.com/currents/post/1323532\" target=\"_blank\">FQ1 pricing guidance</a>. Shares <font color=\"red\">-2.1%</font>.</li>     <li>Synaptics (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SYNA\" title=\"Synaptics Incorporated\">SYNA</a>) has been cut to Neutral by JPMorgan two days after announcing the <a href=\"https://seekingalpha.com/currents/post/1321542\" target=\"_blank\">Validity Sensors deal</a> and forecasting strong FQ1 sales. Shares <font color=\"red\">-1.5%</font>.</li>     <li>Corning (NYSE:<a href=\"https://seekingalpha.com/symbol/GLW\" title=\"Corning Inc.\">GLW</a>) has been cut to Neutral by Piper. Shares <font color=\"red\">-1%</font>.</li>     <li>Iron Mountain (NYSE:<a href=\"https://seekingalpha.com/symbol/IRM\" title=\"Iron Mountain Inc.\">IRM</a>) has been cut to Underweight by Barclays a day after announcing CFO Brian McKeon is <a href=\"https://seekingalpha.com/currents/post/1322102\" target=\"_blank\">leaving</a>. Shares <font color=\"red\">-2.2%</font>.</li>     <li>LG Display (NYSE:<a href=\"https://seekingalpha.com/symbol/LPL\" title=\"LG Display Co., Ltd.\">LPL</a>) has been upgraded to Buy by Citi.</li>     <li>Diodes (NASDAQ:<a href=\"https://seekingalpha.com/symbol/DIOD\" title=\"Diodes Incorporated\">DIOD</a>) has been upgraded to Buy by Longbow.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1324272\" data-linked=\"A roundup of tech ratings changes\" data-tweet=\"$INTC $INTC $NVDA - A roundup of tech ratings changes https://seekingalpha.com/news/1324272-a-roundup-of-tech-ratings-changes?source=tweet\" data-url=\"https://seekingalpha.com/news/1324272-a-roundup-of-tech-ratings-changes\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1324242\" data-ts=\"1381497135\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SSW\" target=\"_blank\">SSW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1324242-seaspan-drops-plan-for-public-offerings-shares-plus-15-percent-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Seaspan drops plan for public offerings, shares +15% premarket</a></h4><ul>     <li>Seaspan (NYSE:<a href=\"https://seekingalpha.com/symbol/SSW\" title=\"Seaspan Corporation\">SSW</a>) <font color=\"green\">+14.9%</font> premarket after disclosing it will <a href=\"http://finance.yahoo.com/news/seaspan-announces-termination-public-offerings-231251179.html\" target=\"_blank\">no longer proceed</a> with its previously announced public offerings of common shares and convertible notes.</li>\n<li>Shares had dropped 17% since the <a href=\"https://seekingalpha.com/currents/post/1317422\" target=\"_blank\">announcement</a> after the close Monday.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1324242\" data-linked=\"Seaspan drops plan for public offerings, shares +15% premarket\" data-tweet=\"$SSW - Seaspan drops plan for public offerings, shares +15% premarket https://seekingalpha.com/news/1324242-seaspan-drops-plan-for-public-offerings-shares-plus-15-percent-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/1324242-seaspan-drops-plan-for-public-offerings-shares-plus-15-percent-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1324232\" data-ts=\"1381497090\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1324232-premarket-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers / Losers</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/SSW' title='Seaspan Corporation'>SSW</a> <font color='green'>+15%</font>. SCTY <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/OCLR' title='Oclaro, Inc.'>OCLR</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/TWGP' title='Tower Group, Inc.'>TWGP</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/SWY' title='Safeway Inc.'>SWY</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/PCYC' title='Pharmacyclics, Inc.'>PCYC</a> <font color='green'>+6%</font>. RSOL <font color='green'>+5%</font>. <a href='https://seekingalpha.com/symbol/INFY' title='Infosys Limited, Inc.'>INFY</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/ECYT' title='Endocyte, Inc.'>ECYT</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/SGI' title='Silicon Graphics Inc.'>SGI</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/EOPN' title='E2open'>EOPN</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/NPSP' title='NPS Pharmaceuticals, Inc.'>NPSP</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/FRO' title='Frontline Ltd.'>FRO</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/GPS' title='The Gap, Inc.'>GPS</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"1324232\" data-linked=\"Premarket Gainers / Losers\" data-tweet=\"$SSW $TSLA $OCLR - Premarket Gainers / Losers https://seekingalpha.com/news/1324232-premarket-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/1324232-premarket-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:11 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1324202\" data-ts=\"1381496649\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GPS\" target=\"_blank\">GPS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1324202-retail-watch-if-on-trend-gap-cant-get-it-done-who-can\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Retail watch: If on-trend Gap can&#39;t get it done, who can?</a></h4><ul> <li>Shares of Gap (NYSE:<a href=\"https://seekingalpha.com/symbol/GPS\" title=\"The Gap, Inc.\">GPS</a>) slump in early trading after the retailer showed <a href=\"https://seekingalpha.com/currents/post/1323702\" target=\"_blank\">broad dips</a> in same-store sales across its segments.</li> <li>Gap's report confirmed a <a href=\"https://seekingalpha.com/currents/post/1322442\" target=\"_blank\">week-long trend</a> in the sector of soft mall traffic and a decidedly cautious stance by U.S. consumers.</li> <li>If an on-trend Gap can't ring up the cash register enough, it doesn't bode well for peers such as Aeropostale (NYSE:<a href=\"https://seekingalpha.com/symbol/AEO\" title=\"American Eagle Outfitters, Inc.\">AEO</a>) and Abercrombie &amp; Fitch (NYSE:<a href=\"https://seekingalpha.com/symbol/ANF\" title=\"Abercrombie &amp; Fitch\">ANF</a>) that have been more off-trend with their assortment.</li> <li>GPS <font color=\"red\">-5.2%</font> premarket.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"1324202\" data-linked=\"Retail watch: If on-trend Gap can&#39;t get it done, who can?\" data-tweet=\"$GPS $GPS $AEO - Retail watch: If on-trend Gap can&#39;t get it done, who can? https://seekingalpha.com/news/1324202-retail-watch-if-on-trend-gap-cant-get-it-done-who-can?source=tweet\" data-url=\"https://seekingalpha.com/news/1324202-retail-watch-if-on-trend-gap-cant-get-it-done-who-can\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:04 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1324162\" data-ts=\"1381495796\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PCYC\" target=\"_blank\">PCYC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1324162-street-darling-pharmacyclics-upgraded-at-goldman\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Street darling Pharmacyclics upgraded at Goldman</a></h4><ul>\n<li>Goldman is out with some <a href=\"http://www.streetinsider.com/Analyst+Comments/Pharmacyclics%27+%28PCYC%29+Ibrutinib+Has+%247.5B+Potential%3B+Goldman+Upgrades+to+Buy%2C+PT+%24170/8769959.html\" target=\"_blank\">new estimates</a> for Pharmacyclics' (NASDAQ:<a href=\"https://seekingalpha.com/symbol/PCYC\" title=\"Pharmacyclics, Inc.\">PCYC</a>) Ibrutinib.</li>\n<li>Analyst Navdeep Singh sees a $5B opportunity in CLL and a $2.5B opportunity in MCL, WM, and DLBCL.</li>\n<li>Singh's price target is upped to $170 (from $111), representing a <font color=\"green\">38%</font> premium to Thursday's close.</li>\n<li>Optimism surrounding <a href=\"https://seekingalpha.com/currents/search?query=ibrutinib\" target=\"_blank\">Ibrutinib</a> has reached a fever pitch, and some estimates peg the drug's potential as high as $9B.</li>\n<li>PCYC <font color=\"green\">+6.3%</font> premarket.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1324162\" data-linked=\"Street darling Pharmacyclics upgraded at Goldman\" data-tweet=\"$PCYC - Street darling Pharmacyclics upgraded at Goldman https://seekingalpha.com/news/1324162-street-darling-pharmacyclics-upgraded-at-goldman?source=tweet\" data-url=\"https://seekingalpha.com/news/1324162-street-darling-pharmacyclics-upgraded-at-goldman\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1324102\" data-ts=\"1381493891\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ECYT\" target=\"_blank\">ECYT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1324102-endocyte-falls-as-vintafolide-monotherapy-unlikely-to-show-nsclc-pfs-superiority\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Endocyte falls as vintafolide monotherapy unlikely to show NSCLC PFS superiority</a></h4><ul>\n<li>Endocyte (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ECYT\" title=\"Endocyte, Inc.\">ECYT</a>) plummets as the DSMB for TARGET advises investigators and patients that vintafolide monotherapy is not likely to be declared superior in PFS to docetaxel.</li>\n<li>The Phase 2b trial had two arms, vintafolide monotherapy and vintafolide in combination with docetaxel, which were to be compared with standard of care (docetaxel monotherapy).</li>\n<li>The DSMB did recommend the continuation of the combination therapy arm.</li>\n<li>Top-line results are due early next year. (PR)</li>\n<li>ECYT <font color=\"red\">-27.4%</font> premarket</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1324102\" data-linked=\"Endocyte falls as vintafolide monotherapy unlikely to show NSCLC PFS superiority\" data-tweet=\"$ECYT - Endocyte falls as vintafolide monotherapy unlikely to show NSCLC PFS superiority https://seekingalpha.com/news/1324102-endocyte-falls-as-vintafolide-monotherapy-unlikely-to-show-nsclc-pfs-superiority?source=tweet\" data-url=\"https://seekingalpha.com/news/1324102-endocyte-falls-as-vintafolide-monotherapy-unlikely-to-show-nsclc-pfs-superiority\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1324072\" data-ts=\"1381493375\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MLCO\" target=\"_blank\">MLCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1324072-golden-week-traffic-sets-up-well-for-melco-crown\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Golden Week traffic sets up well for Melco Crown</a></h4><ul> <li>Golden Week <a href=\"http://www.macaubusiness.com/news/almost-900000-tourist-arrivals-in-golden-week.html\" target=\"_blank\">brought in</a> 900K tourists to Macau, including a 12.1% increase in arrivals from Mainland China.</li> <li>The purest play on Macau gaming is Melco Crown (MPEL) which is now forecast to beat early estimates for Golden Week revenue.</li> <li>MPEL <font color=\"green\">+1.1%</font> premarket.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"1324072\" data-linked=\"Golden Week traffic sets up well for Melco Crown\" data-tweet=\"$MLCO - Golden Week traffic sets up well for Melco Crown https://seekingalpha.com/news/1324072-golden-week-traffic-sets-up-well-for-melco-crown?source=tweet\" data-url=\"https://seekingalpha.com/news/1324072-golden-week-traffic-sets-up-well-for-melco-crown\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:09 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1323952\" data-ts=\"1381490492\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JPM\" target=\"_blank\">JPM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1323952-litigation-costs-push-jpmorgan-into-q3-loss-shares-gain\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Litigation costs push JPMorgan into Q3 loss; shares gain</a></h4><ul>\n<li>EPS of $1.42 excludes litigation expense and reserves of $7.2B (vs. less than $1B a year ago), or $1.85 per share and also excludes the benefit of reserve releases of $992M, or $0.26 per share.</li>\n<li>Dimon: \"The Board continues to seek a fair and reasonable settlement with the government on mortgage-related issues and one that recognizes the extraordinary circumstances of the Bear Stearns and WAMU transactions, which were undertaken at the request or encouragement of the U.S. Government.\"</li>\n<li>Consumer &amp; Community Banking revenue of $11.1B is off 13% Y/Y. Tipped weakness on mortgage banking doesn't disappoint, with <strong>n</strong><strong>oninterest revenue off 27%</strong>. Total mortgage originations fell 17% from Q2, but that's all refi business as purchase originations rose 15%.</li>\n<li>Investment banking revenue of $8.2B is off 2% Y/Y, but includes a $397M DVA charge.</li>\n<li>Commercial banking revenue of $1.7B is off 7% Y/Y.</li>\n<li>Basel Tier 1 common ratio of 10.5%</li>\n<li>\n<a href=\"http://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.jpmorganchase.com&amp;esheet=50727072&amp;newsitemid=20131011005287&amp;lan=en-US&amp;anchor=www.jpmorganchase.com&amp;index=2&amp;md5=17cf06f5b6a6b758ff2d22cb2c74f887\" target=\"_blank\">CC</a> at 8:30 ET.</li>\n<li>\n<a href=\"https://seekingalpha.com/symbol/JPM\" title=\"JPMorgan Chase &amp; Co.\">JPM</a> <font color=\"green\">+1.4%</font> premarket.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1323952\" data-linked=\"Litigation costs push JPMorgan into Q3 loss; shares gain\" data-tweet=\"$JPM - Litigation costs push JPMorgan into Q3 loss; shares gain https://seekingalpha.com/news/1323952-litigation-costs-push-jpmorgan-into-q3-loss-shares-gain?source=tweet\" data-url=\"https://seekingalpha.com/news/1323952-litigation-costs-push-jpmorgan-into-q3-loss-shares-gain\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1323892\" data-ts=\"1381489259\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1323892-a-del-monte-reunion\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">A Del Monte reunion</a></h4><ul> <li>Del Monte Pacific <a href=\"http://www.bloomberg.com/news/2013-10-11/del-monte-pacific-to-pay-1-68-billion-for-u-s-foods-business.html\" target=\"_blank\">agrees to pay</a> $1.68B for the consumer food business of ex-parent Del Monte Foods.</li> <li>The acquisition will give the company a quick entry into the U.S.</li> <li>The deal is expected to close by the end of the first quarter in 2014.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"1323892\" data-linked=\"A Del Monte reunion\" data-tweet=\"A Del Monte reunion https://seekingalpha.com/news/1323892-a-del-monte-reunion?source=tweet\" data-url=\"https://seekingalpha.com/news/1323892-a-del-monte-reunion\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:00 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1323852\" data-ts=\"1381488540\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1323852-crude-oil-slides-as-iea-bullish-about-supply\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Crude oil slides as IEA bullish about supply</a></h4><ul>\n<li>Non-OPEC supplies are expected to increase by a near-record 1.7M barrels per day to 56.4m next year, says the IEA <a href=\"http://www.iea.org/newsroomandevents/news/2013/october/ieareleasesoilmarketreportforoctober.html\" target=\"_blank\">in its monthly report</a>. In addition to the big supply number, the IEA also slightly trimmed its world demand estimate - now seeing an increase of 1.1M barrels to 92M barrels per day.</li>\n<li>\"If the IEA picture on the supply side is correct, there is a real risk that Brent prices (<a href=\"https://seekingalpha.com/symbol/bno\" title=\"The United States Brent Oil ETF, LP\">BNO</a>) will drop below $100 a barrel during 2014,\" says analyst Hannes Loacker.</li>\n<li>WTI crude <font color=\"red\">-1.3%</font> to $101.64. Brent<font color=\"red\"> -0.3%</font> to $111.45.</li>\n<li>Oil ETFs: <a href=\"https://seekingalpha.com/symbol/oil\" title=\"iPath S&amp;P Crude Oil Total Return Index ETN\">OIL</a>, <a href=\"https://seekingalpha.com/symbol/uso\" title=\"The United States Oil ETF, LP\">USO</a>, <a href=\"https://seekingalpha.com/symbol/dbo\" title=\"PowerShares DB Oil ETF\">DBO</a>, <a href=\"https://seekingalpha.com/symbol/olo\" title=\"PowerShares DB Crude Oil Long ETN\">OLO</a>, <a href=\"https://seekingalpha.com/symbol/usl\" title=\"The United States 12 Month Oil ETF, LP\">USL</a>, <a href=\"https://seekingalpha.com/symbol/crud\" title=\"Teucrium WTI Crude Oil ETF\">CRUD</a>, <a href=\"https://seekingalpha.com/symbol/uco\" title=\"ProShares Ultra DJ-UBS Crude Oil ETF\">UCO</a>, <a href=\"https://seekingalpha.com/symbol/dto\" title=\"PowerShares DB Crude Oil Double Short ETN\">DTO</a>, <a href=\"https://seekingalpha.com/symbol/sco\" title=\"ProShares UltraShort DJ-UBS Crude Oil ETF\">SCO</a>, <a href=\"https://seekingalpha.com/symbol/szo\" title=\"PowerShares DB Crude Oil Short ETN\">SZO</a>, <a href=\"https://seekingalpha.com/symbol/dno\" title=\"The United States Short Oil ETF, LP\">DNO</a>, <a href=\"https://seekingalpha.com/symbol/uwti\" title=\"VelocityShares 3x Long Crude Oil ETN\">UWTI</a>, <a href=\"https://seekingalpha.com/symbol/dwti\" title=\"VelocityShares 3x Inverse Crude Oil ETN\">DWTI</a>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1323852\" data-linked=\"Crude oil slides as IEA bullish about supply\" data-tweet=\"$BNO $OIL $USO - Crude oil slides as IEA bullish about supply https://seekingalpha.com/news/1323852-crude-oil-slides-as-iea-bullish-about-supply?source=tweet\" data-url=\"https://seekingalpha.com/news/1323852-crude-oil-slides-as-iea-bullish-about-supply\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1323812\" data-ts=\"1381481820\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1323812-world-stocks-rise-on-hopes-of-u-s-debt-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">World stocks rise on hopes of U.S. debt deal</a></h4><ul>     <li>\n<a href=\"http://www.bloomberg.com/news/2013-10-10/u-s-futures-slip-amid-debt-talks-as-dollar-pares-gains.html\" target=\"_blank\">Global equities</a> are mostly higher on optimism that Washington will come to an agreement to lift the debt ceiling, at least for the short term.</li>     <li>Republican Representative Pete Sessions is <a href=\"https://seekingalpha.com/currents/post/1323752\" target=\"_blank\">even hopeful</a> that a deal could be finalized today.</li>     <li>Japan <font color=\"green\">+1.5%</font>, Hong Kong <font color=\"green\">+1.2%</font>, China <font color=\"green\">+1.7%</font>, India <font color=\"green\">+1%</font>.</li>     <li>EU Stoxx 50 <font color=\"green\">+0.3%</font>, London <font color=\"green\">+0.6%</font>, Paris flat, Frankfurt <font color=\"green\">+0.5%</font>, Milan <font color=\"green\">+0.1%</font>, Madrid flat.</li>     <li>U.S. Stock futures: Dow <font color=\"green\">+0.2%</font>, S&amp;P <font color=\"green\">+0.15%</font> and Nasdaq <font color=\"green\">+0.2%</font>, adding to sharp gains on Wall Street yesterday.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1323812\" data-linked=\"World stocks rise on hopes of U.S. debt deal\" data-tweet=\"World stocks rise on hopes of U.S. debt deal https://seekingalpha.com/news/1323812-world-stocks-rise-on-hopes-of-u-s-debt-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/1323812-world-stocks-rise-on-hopes-of-u-s-debt-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:57 AM </div></div></li>","count":38,"message":null,"success":true,"today":{"start":1576818000,"end":1576904399,"str":"Friday, December 20, 2019"},"yesterday":{"start":1576731600,"end":1576817999}}